Becario en Investigación Clínica (Trial Capabilities) at Eli Lilly and Company

Mexico City, Mexico City, Mexico

Eli Lilly and Company Logo
Not SpecifiedCompensation
InternshipExperience Level
Part TimeJob Type
UnknownVisa
Pharmaceuticals, Healthcare, Clinical ResearchIndustries

Requirements

  • Estudias alguna licenciatura o ingeniería del área de ciencias de la salud
  • Te falta al menos un año y medio para titularte
  • Tienes interés por desarrollarte en el área de investigación en salud
  • Cuentas con disponibilidad para trabajar 30 horas a la semana (idealmente, 6 horas diarias, por la mañana)
  • Alta atención al detalle
  • Sentido de urgencia y priorización
  • Capacidad de análisis
  • Organización eficiente
  • Proactividad y ser propositivo
  • Comunicación clara y asertiva
  • Inglés avanzado

Responsibilities

  • Revisión de oficios de autorización de COFEPRIS para detectar errores u omisiones; sometimiento de la corrección(es) correspondiente
  • Elaboración y sometimiento a COFEPRIS de informes anuales y finales de los estudios desarrollados en México
  • Revisión de paquetes de sometimiento ante COFEPRIS
  • Revisión de calidad de Consentimientos Informados (documento entregado a los pacientes) antes de que compartirlos con los Centros de Investigación
  • Archivo de documentos de los estudios en el electronic Trial Master File (eTMF)
  • Actualización de las bases de datos regulatorias del área
  • Gestión del proceso de contratos entre Lilly y los Centros de Investigación (creación, envío, recolección, resguardo)

Skills

COFEPRIS
Regulatory Submissions
Clinical Trials
eTMF
Informed Consent
Document Review
Quality Assurance
Protocol Management
Contract Creation
Staff Training

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI